WALTHAM, Mass., Sept. 29, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR) (the "Company"), a global leader in rapid diagnostic tests, today announced the U.S. Department of Justice (the "DOJ") has closed the previously announced investigation into, among other things, sales, sales practices and dealings with certain third parties, without taking any action against Alere. The DOJ investigation primarily involved matters occurring at foreign subsidiaries previously acquired by the Company.
Alere issued the following statement:
We are pleased that this matter has been closed with no action taken against Alere.
Alere believes that when diagnosing and monitoring health conditions, Knowing now matters™. Alere delivers reliable and actionable information by providing rapid diagnostic tests, enhancing clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for cardiometabolic disease, infectious disease and toxicology.
For more information on Alere, please visit www.alere.com.
SOURCE Alere Inc.